New drug MSD-001 tested in healthy volunteers for safety
Knowledge-focused
Completed
This early-stage trial tested a single dose of MSD-001 in 47 healthy adults to see if it is safe and how the body processes it. The drug is being developed as part of a future combination treatment for mental health conditions. The study is now complete.
Phase: PHASE1 • Sponsor: Mindstate Design Labs • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:16 UTC